Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Drug discovery in the context of precision medicine and artificial intelligence
6
Zitationen
7
Autoren
2024
Jahr
Abstract
Introduction The drug development process traditionally includes rigorous pre-clinical testing in laboratories and animal models to assess the safety, efficacy, pharmacokinetics, and toxicology of potential drug candidates before progressing to human clinical trials. Developing AI, machine ML algorithms, and PM approaches will facilitate identifying potential drug targets, predicting therapeutic outcomes, and optimizing the selection of lead compounds.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.239 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.095 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.463 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.428 Zit.